Episode Details
Back to Episodes
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
Season 1
Published 2 years, 11 months ago
Description
Professor Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here